See the DrugPatentWatch profile for cosentyx

Based on the information provided, I cannot confirm whether a discussion about Cosentyx and any related concerns has taken place with a doctor. However, I can provide some context about Cosentyx that may be helpful in such a conversation.

Cosentyx, also known as secukinumab, is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body that contributes to inflammation [1].

Before starting Cosentyx, it is essential to discuss potential concerns with a healthcare professional. Some possible concerns may include:

1. Allergic reactions: Although rare, some people may experience allergic reactions to Cosentyx. Symptoms can include hives, swelling, and difficulty breathing [1].
2. Infections: Cosentyx can increase the risk of infections, including tuberculosis and other opportunistic infections. Patients should inform their doctor if they have a history of infections or are at risk of developing infections [1].
3. Vaccinations: Live vaccines should be avoided while taking Cosentyx. Patients should discuss their vaccination status and any upcoming vaccinations with their healthcare provider [1].
4. Use during pregnancy and breastfeeding: The safety of Cosentyx during pregnancy and breastfeeding is not fully established. Pregnant women or those planning to become pregnant should consult their doctor [1].
5. Monitoring: Regular monitoring of liver function, cholesterol levels, and complete blood counts may be necessary while taking Cosentyx [1].

It is essential to consult the prescribing information and discuss any concerns with a healthcare professional before starting Cosentyx or any other medication [1].

Sources:
[1] DrugPatentWatch.com. (n.d.). Cosentyx (secukinumab) Drug Information. Retrieved from https://www.drugpatentwatch.com/drugs/cosentyx